A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats

British Journal of Pharmacology

Volumn 160, Issue 3, 2010, Pages 574-584

  Zakrzeska, Agnieszka ^a   Schlicker, Eberhard ^b   Baranowska, Marta ^a   Kozłowska, Hanna ^a   Kwolek, Grzegorz ^a   Malinowska, Barbara ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Anaesthetized rat; Anandamide; Cannabidiol; Cannabinoid receptors; Endothelial cannabinoid receptor; Haemodynamic responses; Methanandamide; O 1918; Pithed rat

Indexed keywords

1,3 DIMETHOXY 5 2 [3 METHYL 6 (1 METHYLETHENYL) 2 CYCLOHEXEN 1 YL] BENZENE; ANANDAMIDE; CANNABIDIOL; CANNABINOID 1 RECEPTOR ANTAGONIST; METHANANDAMIDE; O 1918; UNCLASSIFIED DRUG; VASOPRESSIN; 1,3-DIMETHOXY-5-METHYL-2-(3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)BENZENE; AMIDE; ANISOLE DERIVATIVE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR ANTAGONIST; CYCLOHEXANE DERIVATIVE; ENDOCANNABINOID;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART RATE; HYPOTENSION; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; ANESTHESIA; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY CIRCULATION; PROCEDURES; SPLANCHNIC BLOOD FLOW; WISTAR RAT;

ANESTHESIA; ANIMALS; ANISOLES; ARACHIDONIC ACIDS; BLOOD PRESSURE; CANNABIDIOL; CANNABINOID RECEPTOR ANTAGONISTS; CYCLOHEXANES; ENDOCANNABINOIDS; HYPOTENSION; MALE; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; RENAL CIRCULATION; SPLANCHNIC CIRCULATION;

EID: 77952608287     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00579.x     Document Type: Article

References (33)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Bátkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J et al. (2004). Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110 : 1996 2002.
3. 1 spinal receptors in urethane-anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 368 : 270 276.
4. Garcia N, Járai Z, Mirshahi F, Kunos G, Sanyal AJ (2001). Systemic and portal hemodynamic effects of anandamide. Am J Physiol Gastrointest Liver Physiol 280 : G14 G20.
5. Gardiner SM, March JE, Kemp PA, Bennet T (2002). Complex regional haemodynamic effects of anandamide in conscious rats. Br J Pharmacol 135 : 1889 1896.
6. Gardiner SM, March JE, Kemp PA, Bennet T (2009). Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats. Br J Pharmacol (on line).
7. Giuffrida A, Beltramo M, Piomelli D (2001). Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exp Ther 298 : 7 14.
8. + channels. J Pharmacol Exp Ther 328 : 351 361.
9. Ho WS, Gardiner SM (2009). Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats. Br J Pharmacol 156 : 94 104.
10. Ho WS, Hiley CR (2003). Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br J Pharmacol 138 : 1320 1332.
11. Ho WS, Hiley CR (2004). Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. J Pharm Pharmacol 56 : 869 875.
12. 2 receptors. Proc Natl Acad Sci 96 : 14136 14141.
13. Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA et al. (2007). The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br J Pharmacol 152 : 825 831.
14. Koura Y, Ichihara A, Tada Y, Kaneshiro Y, Okada H, Temm CJ et al. (2004). Anandamide decreases glomerular filtration rate through predominant vasodilation of efferent arterioles in rat kidneys. J Am Soc Nephrol 15 : 1488 1494.
15. Kozłowska H, Baranowska M, Schlicker E, Kozłowski M, Laudański J, Malinowska B (2007). Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery. J Hypertens 25 : 2240 2248.
16. Kozłowska H, Baranowska M, Schlicker E, Kozłowski M, Laudański J, Malinowska B (2008). Virodhamine relaxes the human pulmonary through the endothelial cannabinoid receptor and indirectly through a COX product. Br J Pharmacol 155 : 1034 1042.
17. Kurz C, Baranowska U, Łupiński S, Göthert M, Malinowska B, Schlicker E (2009). Urethane, but not pentobarbitone, attenuates presynaptic receptor function in rats: a contribution to the choice of anaesthetic. Br J Pharmacol 157 : 1474 1482.
18. Kwolek G, Zakrzeska A, Schlicker E, Göthert M, Godlewski G, Malinowska B (2005). Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. Br J Pharmacol 145 : 567 575.
19. Lake KD, Martin BR, Kunos G, Varga K (1997). Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29 : 1204 1210.
20. 1 receptor knockout mice. Science 283 : 401 404.
21. 3 receptors in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol 347 : 55 60.
22. 1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol 356 : 197 202.
23. 1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 364 : 562 569.
24. 1 receptors. Naunyn Schmiedebergs Arch Pharmacol 364 : 233 241.
25. Malinowska B, Łupiński S, Godlewski G, Baranowska U, Schlicker E (2008). Role of endocannabinoids in cardiovascular shock. J Physiol Pharmacol 59 (Suppl. 8 91 107.
26. Niederhoffer N, Schmidt K, Szabo B (2003). The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. Naunyn Schmiedebergs Arch Pharmacol 367 : 434 443.
27. Offertáler L, Mo FM, Bátkai S, Liu J, Begg M, Razdan RK et al. (2003). Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63 : 699 705.
28. 1 receptor knock-out mice. J Physiol 558 : 647 657.
29. Pacher P, Mukhopadhyay P, Mohanraj R, Godlewski G, Bátkai S, Kunos G (2008). Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Hypertension 52 : 601 607.
30. Pertwee RG (2007). GPR55: a new member of the cannabinoid receptor clan? Br J Pharmacol 152 : 984 986.
31. 2 receptor agonists in vitro. Br J Pharmacol 150 : 613 623.
32. 1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278 : 279 283.
33. Wagner JA, Varga K, Járai Z, Kunos G (1999). Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33 : 429 434.